Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Average Recommendation of "Moderate Buy" from Analysts
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat reports...